The Impact of Covid-19 Pandemic on the Castile and Leon Addiction Treatment Network
A Real-Word Experience
Bibliographic Data
Background: Patients suffering from addiction are a vulnerable group in the midst of COVID-19, so their healthcare is considered essential. In this paper, the measures and responses of the Drug Addiction Assistance Network of Castile and Leon (DAACYL) in Spain during the first 6 weeks of the COVID-19 pandemic are explained. The aim is that this experience could be useful in places where this problem will continue and could help future interventions. Methods: A telephone survey was carried out as the main methodology, to collect information for the subsequent organization and repercussion on professionals and patients. This was carried out by the heads of the 18 DAACYL units. Among the interventions applied, the following stand out: implantation of telemedicine techniques, restriction of daily methadone dispensing, suspension of urine controls and initiation of care programs for the homeless. Results: As a result of these interventions, the professionals observed that patients are less demanding and mostly stable, with a low percentage of relapses. An increase in the consumption of alcohol and benzodiazepines have been reported as more common among people who relapse. Furthermore, the prevalence of COVID-19 infection in the sample is minimal; therefore, different hypotheses should be considered as an explanation (infra-diagnosis, immune system used to aggression, possible anti-inflammatory effect of some psychotropic drugs and a greater perception of danger against infection than the general population). Conclusions: The rapid adaptation and successful implementation of DAACYL have had satisfactory results. On the other hand, the prevention of the possible increase in the development of behavioral addictions and the use of homemade drugs should be considered
Addiction · Coronavirus disease 2019 (COVID-19 · Disease · Environmental health · Family medicine · Health care · Methadone · Pandemic · Population · Psychiatry · Psychological intervention · COVID-19 and Mental Health · Digital Mental Health Interventions · Medicine · Opioid Use Disorder Treatment · Psychology · Internal Medicine
Exercise and Use of Enhancement Drugs at the Time of the Covid-19 Pandemic
Abstinence duration and psychopathology among addiction outpatients during 18 months of Covid-19
Healthcare professionals' perception and satisfaction with mental health tele-medicine during the Covid-19 outbreak
Analysis of Clinical Parameters, Drug Consumption and Use of Health Resources in a Southern European Population with Alcohol Abuse Disorder during Covid-19 Pandemic
Methadone and buprenorphine-related deaths among people prescribed and not prescribed Opioid Agonist Therapy during the Covid-19 pandemic in England
Perceptions of Homeless Adults and Their Providers on Coping With the Impact of Covid-19 Pandemic on Mental Health, Substance Use, and Harm Reduction Services
Collision of the Covid-19 and Addiction Epidemics
Covid-19
Progression of Mental Health Services during the Covid-19 Outbreak in China
Addressing the Covid-19 Pandemic in Populations With Serious Mental Illness
Online mental health services in China during the Covid-19 outbreak
HIV And HCV infection among opiate-dependent patients and methadone doses
Covid‐19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities
Using a mobile health application to reduce alcohol consumption
Success and failure in narrowing the disability employment gap
Opioid-related deaths in Europe
| Unique citing works | 6 |
|---|---|
| Citations per year | 1,2 |
| Citation span | 2021 - 2024 (4) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 6 |